OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
2
Results
Show all
Save search
Copy query
Show results for
Unknown
(2)
Publication Date
Release Date
2019
(2)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Not available
S-EPMC6539817
|
biostudies-literature
Cite
BCR-ABL1
Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors.
Not available
S-EPMC6700306
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
